Skip to content
Open access

Preoperative high-sensitivity C-reactive protein-to-albumin ratio predicts arteriovenous fistula failure in hemodialysis patients: a retrospective cohort study with landmark analysis

Sep 2026 · Frontiers in Surgery · Vol 13 · 0 citations · 30 references
Medicine

TL;DR

Preoperative HRR is an independent predictor of AVF failure, and decision curve analysis confirmed its potential utility in preoperative risk stratification, supporting its potential utility in preoperative risk stratification.

Abstract

Background The arteriovenous fistula (AVF) is the preferred vascular access for hemodialysis, yet up to 50% of AVFs fail within the first year due to stenosis or thrombosis. The high-sensitivity C-reactive protein to albumin ratio (HRR) integrates inflammation and nutritional status, but its association with AVF failure has not been systematically evaluated. Methods This retrospective cohort study included 279 patients who underwent first-time AVF creation. HRR was calculated as hsCRP (mg/L) divided by albumin (g/L). The primary outcome was AVF failure (stenosis ≥50% or thrombosis requiring intervention). Multivariate Cox regression adjusted for age, sex, BMI, diabetes, hypertension, smoking, and vessel diameter. Model performance was assessed using time-dependent ROC, calibration curve, and decision curve analysis (DCA). Results During a median follow-up of 50 months, 141 patients (50.5%) developed AVF failure.In multivariate analysis, higher HRR was independently associated with increased AVF failure risk (HR per unit increase = 1.65, 95% CI: 1.33–2.05, P < 0.001), independent of vessel diameter (HR = 0.21, 95% CI: 0.08–0.57, P = 0.002). A landmark analysis stratified at 24 months demonstrated that the predictive effect of HRR was directionally consistent across early (HR = 1.60, 95% CI: 1.27–2.02) and late (HR = 1.47, 95% CI: 0.66–3.29) follow-up periods (P for interaction = 0.766), although the late-phase estimate was imprecise due to the reduced sample size. The model demonstrated moderate discrimination at 24 months (AUC = 0.608, 95% CI: 0.519–0.701) and good calibration. DCA confirmed that incorporating HRR provided positive net clinical benefit across clinically relevant threshold probabilities. The proportional hazards assumption was satisfied (global P = 0.97). Sensitivity analysis using multiple imputation yielded consistent results. Conclusions Preoperative HRR is an independent predictor of AVF failure. Although the model demonstrated weak to moderate discrimination (24-month AUC = 0.608), decision curve analysis confirmed a positive net clinical benefit, supporting its potential utility in preoperative risk stratification. This simple, widely available laboratory-based marker may assist clinicians in identifying high-risk patients and individualizing surveillance intensity, though external validation is warranted.

Read PDF

Similar papers

Open access Nov 2026

Fibrinogen-to-albumin ratio and major adverse cardiovascular events in older patients with heart failure: a retrospective cohort study

The fibrinogen-to-albumin ratio (FAR) integrates information on coagulation, systemic inflammation, and nutritional status; however, its prognostic significance for major adverse cardiovascular events (MACE) in older patients with heart failure (HF) remains insufficiently characterized. This single-center re...

Miao-Miao Li, Bing-Sen Huang, Mei-Hua Du et al. · 0 citations
Open access Oct 2026

Not All Albumin Ratios Are Equal: A Comparative Analysis of Four Biomarkers in Predicting In-Stent Restenosis After ST-Elevation Myocardial Infarction

CALR and UAR emerged as strong and consistent independent predictors of ISR risk in both cross-sectional and long-term analyses, whereas the predictive value of CAR was largely confined to the cross-sectional assessment.

Ali Duygu, Fahri Er, A. Akgümüş et al. · 0 citations
Open access Oct 2026

Prognostic Value of the C-Reactive Protein-to-Albumin Ratio in Patients Hospitalized with Atrioventricular Block: Association with In-Hospital Mortality and Temporary Pacemaker Requirement

Background and Objectives: The C-reactive protein-to-albumin ratio (CAR) is an available marker of inflammatory–nutritional vulnerability, but its prognostic value in atrioventricular (AV) block is unclear. We investigated whether CAR is associated with in-hospital mortality and temporary pacemaker requirement (TPR) in...

K. Parsova, L. Pay, A. Yumurtaş et al. · 0 citations
Open access Sep 2026

Dynamic Assessment of the C-Reactive Protein-to-Albumin Ratio Improves Early Prediction of Severe Acute Pancreatitis: A Retrospective Cohort Study

Background/Objectives: Previous studies have demonstrated the prognostic value of the C-reactive protein-to-albumin ratio (CAR) in acute pancreatitis, but the incremental value of serial measurements remains unclear. We evaluated whether CAR measured at 24 and 48 h provides additional prognostic information beyond admi...

Crina Fofiu, Laura Nat, A. Ioanovici et al. · 0 citations
Oct 2026

C-reactive protein-albumin-lymphocyte index and coronary microvascular dysfunction after primary percutaneous coronary intervention: The mediating role of insulin resistance.

BACKGROUND The C-reactive protein-albumin-lymphocyte (CALLY) index integrates systemic inflammation, nutritional status, and immune function. We investigated its association with angiography-derived microvascular resistance (AMR)-defined coronary microvascular dysfunction (CMD) in patients with ST-segment elevation myo...

Wei Wang, Han-Wei Qiu, Jian Wang et al. · 0 citations
Oct 2026

The C-reactive protein-albumin-lymphocyte (CALLY) index as a predictor of mortality in patients undergoing carotid artery stenting.

Lower CALLY index values were associated with 30-day all-cause mortality after CAS and showed potentially useful discriminatory ability, however, only 11 deaths occurred, resulting in considerable uncertainty around the performance estimates.

M. Keskin, Selami Doğan, L. Öcal et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.